In-Vitro Antioxidant and Anti-Inflammatory Activity of Chamomile Flower
DOI:
https://doi.org/10.64882/ijrt.v14.i1.1107Keywords:
Chamomile Flower, Phytopharmaceutical, BioactivityAbstract
Chamomile flower, botanically identified as Matricaria chamomilla L. or Matricaria recutita L., is one of the most widely used medicinal flowers in traditional and modern herbal medicine. The flower heads contain pharmacologically relevant groups of constituents such as flavonoids, sesquiterpenes, terpenoids, coumarins, phenolic acids and mucilage, among which apigenin, luteolin, quercetin derivatives, alpha-bisabolol, bisabolol oxides, matricine and chamazulene are considered particularly important for anti-inflammatory and antioxidant responses. The findings demonstrate that chamomile flower extract shows concentration-dependent antioxidant and anti-inflammatory activity. In the dataset presented in this thesis, DPPH radical scavenging increased from 24.8% at 50 microgram/mL to 81.9% at 800 microgram/mL, while ABTS scavenging rose from 27.9% to 84.1% across the same concentration range. In the anti-inflammatory assays, inhibition of albumin denaturation increased from 21.4% to 75.8%, and membrane stabilization improved from 25.1% to 79.3%. Paired t-testing showed statistically significant differences between chamomile extract and standards across all assays, indicating that although the extract was less potent than standards, it retained meaningful bioactivity suitable for phytopharmaceutical investigation. A chi-square comparison of response categories showed a similar overall distribution of moderate to high activity across assays.
References
Singh O, Khanam Z, Misra N, Srivastava MK. Chamomile (Matricaria chamomilla L.): An overview. Pharmacogn Rev. 2011;5(9):82-95.
Srivastava JK, Shankar E, Gupta S. Chamomile: A herbal medicine of the past with bright future. Mol Med Rep. 2010;3(6):895-901.
Srivastava JK, Pandey M, Gupta S. Chamomile, a novel and selective COX-2 inhibitor with anti-inflammatory activity. Life Sci. 2009;85(19-20):663-669.
Srivastava JK, Pandey M, Gupta S. Chamomile, an anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity. Int J Mol Med. 2010;26(6):935-940.
Dai YL, Li X, Wu Q, et al. Chamomile: A review of its traditional uses, chemical constituents, pharmacological activities and quality control studies. Molecules. 2022;27(24):1-31.
El Mihyaoui A, Candela Castillo ME, Cano Lamadrid M, et al. Chamomile (Matricaria chamomilla L.): A review of ethnomedicinal use, phytochemistry and pharmacological uses. Life (Basel). 2022;12(4):479.
Sah A, Juyal V, Melkani AB. A comprehensive study of therapeutic applications of chamomile. Pharmaceuticals (Basel). 2022;15(11):1-36.
European Medicines Agency. European Union herbal monograph on Matricaria recutita L., flos. London: EMA; 2015.
European Medicines Agency. Assessment report on Matricaria recutita L., flos and Matricaria recutita L., aetheroleum. London: EMA; 2015.
Miraj S, Alesaeidi S. A systematic review study of therapeutic effects of Matricaria recutita chamomile. Electron Physician. 2016;8(9):3024-3031.
McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res. 2006;20(7):519-530.
Ullah A, Munir S, Badshah SL, et al. Important flavonoids and their role as a therapeutic agent. Molecules. 2020;25(22):5243.
Salehi B, Venditti A, Sharifi-Rad M, et al. The therapeutic potential of apigenin. Int J Mol Sci. 2019;20(6):1305.
Wang M, Firrman J, Liu L, Yam K. A review on flavonoid apigenin: Dietary intake, ADME, antimicrobial effects and mechanisms. Biomed Pharmacother. 2019;120:109420.
Tsivelika N, Santas J, Aligiannis N, et al. Phenolic profile by HPLC-PDA-MS of Greek chamomile populations and antioxidant activity. Plants (Basel). 2021;10(11):2345.
Downloads
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.




